Results 21 to 30 of about 23,362 (196)
Рациональная фармакотерапия в кардиологии, 2022 Aim. The aim of this work was to study the occurrence of the rs776746 allelic variant of the CYP3A5 gene and its effect on heart rate (HR) when using bisoprolol in patients hospitalized with acute coronary syndrome (ACS).Materials and methods.
V. A. Shumkov +3 more
doaj +1 more source
Beta-blocker under-use in COPD patients [PDF]
, 2017 Background: Cardiovascular (CVS) comorbidities are common in COPD and contribute significantly to morbidity and mortality, especially following acute exacerbations of COPD (AECOPD).
Lavender, Melanie +4 more
core +2 more sources
Prevalence of drug-herb and drug-supplement interactions in older adults : A cross-sectional survey [PDF]
, 2018 © British Journal of General PracticeBackground Polypharmacy is common among older adults, with increasing numbers also using prescription drugs with herbal medicinal products (HMPs) and dietary supplements.
Agbabiaka +19 more
core +2 more sources
CPT: Pharmacometrics & Systems Pharmacology, 2021 Merck KGaA observed slight differences in the dissolution of Concor® (bisoprolol) batches over the years. The purpose of this work was to assess the impact of in vitro dissolution on the simulated pharmacokinetics of bisoprolol using in vitro–in vivo ...
Joyce S. Macwan +4 more
doaj +1 more source
THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE
Рациональная фармакотерапия в кардиологии, 2016 Data of the evidence based medicine about bisoprolol treatment of patients with cardiovascular diseases (arterial hypertension, ischemic heart disease, chronic heart failure, rhythm disorders) are presented.
Yu. V. Lukina, S. Yu. Martsevich
doaj +1 more source
Autonomic modulation in patients with heart failure increases beat-to-beat variability of ventricular action potential duration [PDF]
, 2017 Background: Exaggerated beat-to-beat variability of ventricular action potential duration (APD) is linked to arrhythmogenesis. Sympathetic stimulation has been shown to increase QT interval variability, but its effect on ventricular APD in humans has not
Behar, Jonathan +11 more
core +2 more sources
КардиоСоматика, 2020 Aim.Compare the effects of bisoprolol, nebivolol and sotalol on the functional state of patients with ventricular arrhythmias (VA). Material and methods.120 patients with VA against the background of essential hypertension or its combination with ...
Iosif Z. Shubitidze, Vitalii G. Tregubov
doaj +1 more source
Managing postoperative atrial fibrillation after open-heart surgery using transdermal β1 blockers
Journal of Cardiothoracic Surgery, 2023 Background Postoperative atrial fibrillation (POAF) after open-heart surgery is a non-negligible complication. We aimed to describe the efficacy of a transdermal patch of bisoprolol for managing POAF and flutter in thoracic surgical procedures.
Kenji Yamamoto +6 more
doaj +1 more source
Plasma N-Terminal Pro-Brain Natriuretic Peptide as Prognostic Marker in Fatal Cardial Decompensation with Sunitinib Malate Therapy [PDF]
, 2010 A 74-year-old man with metastatic renal cell carcinoma and a history of cardiac failure was treated with sunitinib malate. MUGA echocardiography could not detect a relevant change in the ejection fraction although the clinical situation of the patient ...
Haseke, Nicolas +4 more
core +1 more source
Beta-blockers in COPD:time for reappraisal [PDF]
, 2016 The combined effects on the heart of smoking and hypoxaemia may contribute to an increased cardiovascular burden in chronic obstructive pulmonary disease (COPD).
Devereux, Graham +4 more
core +3 more sources